HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Expression of survivin, YB-1, and KI-67 in sporadic adenomas and dysplasia-associated lesions or masses in ulcerative colitis.

Abstract
Sporadic adenomas are said to exhibit an orderly growth pattern with a reversal of proliferative and apoptotic cell distribution as compared with normal colonic crypts. Dysplastic polyps of patients with ulcerative colitis (UC) may represent dysplasia-associated lesions or masses (DALM) with a high associated cancer risk, or, alternatively, may represent sporadic adenomas. Histologic criteria to differentiate between sporadic adenomas and DALM have not focused on the balance between cell renewal and cell loss. The expression of the novel anti-apoptosis gene product, survivin, and the proliferation markers, Ki-67 and Y-box binding protein (YB-1), were investigated by immunohistochemical localization in sporadic adenomas and DALM lesions of patients with UC. In adenomas, KI-67 was expressed preponderantly at the luminal aspect of the polyp, whereas its expression was diffuse in DALM. Survivin was detected diffusely in both adenomas and DALM. YB-1 showed positive staining in the deep aspect of adenomatous glands but only to a minor degree at the surface, whereas both deep and diffuse expression patterns of YB-1 were seen in DALM. The authors conclude that DALM and sporadic adenomas exhibit different patterns of cellular proliferation and that molecular markers of cell proliferation, Ki-67 and YB-1, may be useful to distinguish sporadic adenomas from DALM. However, the similar expression of survivin suggests that the underlying mechanisms that regulate apoptotic cell death are uniform in these lesions.
AuthorsF Fogt, C Poremba, K Shibao, H Itoh, K Kohno, R L Zimmerman, H G Görtz, B Dockhorn-Dworniczak, S J Urbanski, N Alsaigh, D Heinz, A E Noffsinger, K R Shroyer
JournalApplied immunohistochemistry & molecular morphology : AIMM (Appl Immunohistochem Mol Morphol) Vol. 9 Issue 2 Pg. 143-9 (Jun 2001) ISSN: 1541-2016 [Print] United States
PMID11396632 (Publication Type: Journal Article)
Chemical References
  • BIRC5 protein, human
  • CCAAT-Enhancer-Binding Proteins
  • Chromosomal Proteins, Non-Histone
  • Cysteine Proteinase Inhibitors
  • DNA-Binding Proteins
  • Inhibitor of Apoptosis Proteins
  • Ki-67 Antigen
  • Microtubule-Associated Proteins
  • NFI Transcription Factors
  • Neoplasm Proteins
  • Nuclear Proteins
  • Survivin
  • Transcription Factors
  • Y-Box-Binding Protein 1
  • YBX1 protein, human
Topics
  • Adenoma (metabolism, pathology)
  • Animals
  • Base Sequence
  • CCAAT-Enhancer-Binding Proteins (metabolism)
  • Chromosomal Proteins, Non-Histone (genetics, metabolism)
  • Colitis, Ulcerative (metabolism, pathology)
  • Colon (metabolism, pathology)
  • Cysteine Proteinase Inhibitors (metabolism)
  • DNA-Binding Proteins
  • Female
  • Humans
  • Immunoblotting
  • Immunohistochemistry
  • Inhibitor of Apoptosis Proteins
  • Ki-67 Antigen (metabolism)
  • Male
  • Microtubule-Associated Proteins
  • Molecular Sequence Data
  • NFI Transcription Factors
  • Neoplasm Proteins
  • Nuclear Proteins
  • Reverse Transcriptase Polymerase Chain Reaction
  • Survivin
  • Transcription Factors
  • Y-Box-Binding Protein 1

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: